Evidence map›Paper›PMID 27913372›Full record

ArticleJournal of medical Internet research2016

An eHealth Project on Invasive Pneumococcal Disease: Comprehensive Evaluation of a Promotional Campaign.

Donatella Panatto, Alexander Domnich, Roberto Gasparini, Paolo Bonanni, Giancarlo Icardi, Daniela Amicizia, Lucia Arata, Stefano Carozzo, Alessio Signori, Angela Bechini and 1 more

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Donatella PanattoDepartment of Health Sciences, University of Genoa, Genoa, Italy.ORCID 0000-0002-2677-0551
Alexander DomnichDepartment of Health Sciences, University of Genoa, Genoa, Italy.ORCID 0000-0001-9608-8892
Roberto GaspariniDepartment of Health Sciences, University of Genoa, Genoa, Italy.ORCID 0000-0002-1012-6913
Paolo BonanniDepartment of Health Sciences, University of Florence, Florence, Italy.ORCID 0000-0003-2875-3744
Giancarlo IcardiDepartment of Health Sciences, University of Genoa, Genoa, Italy.ORCID 0000-0002-8463-8487
Daniela AmiciziaDepartment of Health Sciences, University of Genoa, Genoa, Italy.ORCID 0000-0002-9707-5214
Lucia ArataDepartment of Health Sciences, University of Genoa, Genoa, Italy.ORCID 0000-0002-8708-2955
Stefano CarozzoDepartment of Health Sciences, University of Genoa, Genoa, Italy.ORCID 0000-0002-8358-4798
Alessio SignoriDepartment of Health Sciences, University of Genoa, Genoa, Italy.ORCID 0000-0001-6289-9144
Angela BechiniDepartment of Health Sciences, University of Florence, Florence, Italy.ORCID 0000-0002-6013-8779
Sara BoccaliniDepartment of Health Sciences, University of Florence, Florence, Italy.ORCID 0000-0002-9695-7549

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe recently launched Pneumo Rischio eHealth project, which consists of an app, a website, and social networking activity, is aimed at increasing public awareness of invasive pneumococcal disease (IPD). The launch of this project was prompted by the inadequate awareness of IPD among both laypeople and health care workers, the heavy socioeconomic burden of IPD, and the far from optimal vaccination coverage in Italy, despite the availability of safe and effective vaccines.

objectiveThe objectives of our study were to analyze trends in Pneumo Rischio usage before and after a promotional campaign, to characterize its end users, and to assess its user-rated quality.

methodsAt 7 months after launching Pneumo Rischio, we established a 4-month marketing campaign to promote the project. This intervention used various approaches and channels, including both traditional and digital marketing strategies. To highlight usage trends, we used different techniques of time series analysis and modeling, including a modified Mann-Kendall test, change-point detection, and segmented negative binomial regression of interrupted time series. Users were characterized in terms of demographics and IPD risk categories. Customer-rated quality was evaluated by means of a standardized tool in a sample of app users.

resultsOver 1 year, the app was accessed by 9295 users and the website was accessed by 143,993 users, while the project's Facebook page had 1216 fans. The promotional intervention was highly effective in increasing the daily number of users. In particular, the Mann-Kendall trend test revealed a significant (P ≤.01) increasing trend in both app and website users, while change-point detection analysis showed that the first significant change corresponded to the start of the promotional campaign. Regression analysis showed a significant immediate effect of the intervention, with a mean increase in daily numbers of users of 1562% (95% CI 456%-4870%) for the app and 620% (95% CI 176%-1777%) for the website. Similarly, the postintervention daily trend in the number of users was positive, with a relative increase of 0.9% (95% CI 0.0%-1.8%) for the app and 1.4% (95% CI 0.7%-2.1%) for the website. Demographics differed between app and website users and Facebook fans. A total of 69.15% (10,793/15,608) of users could be defined as being at risk of IPD, while 4729 users expressed intentions to ask their doctor for further information on IPD. The mean app quality score assigned by end users was approximately 79.5% (397/500).

conclusionsDespite its specific topic, Pneumo Rischio was accessed by a considerable number of users, who ranked it as a high-quality project. In order to reach their target populations, however, such projects should be promoted.

Indexed as

AdolescentAdultAgedFemaleHumansMaleMiddle AgedMobile ApplicationsPneumococcal InfectionsStreptococcus pneumoniaeTelemedicineYoung AdulteHealthinvasive pneumococcal diseasemHealthmobile apppneumococcus

Identifiers

PMID27913372
PMCPMC5161781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.